Work

Nephrotoxicity of Iodinated Contrast Drugs: A Comparative Analysis of Old Versus New, Ionic Versus Non Ionic Agents, Dose Effects, and the Impact of Relative Dehydration in Stroke Patients

Year: 2024
Type: article
Abstract: 1. Shafaat O, Sotoudeh H (2024) Stroke Imaging. In: StatPearls Treasure Island (FL): StatPearls Publishing: https://www.ncbi.nlm.nih.gov/books/NBK546635/ 2. Hand P J, Kwan J, Lindley RI, Dennis MS, Wardlaw JM (2006) Distinguishing between stroke and mimic at the bedside: the brain attack study Stroke 37: 769-775.3. Murphy A, Hutson R, Bell D (2023) Iodinated contrast media. Radiopaedia.org https://radiopaedia.org/articles/iodinated-contrast-media-1?lang=us 4. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, et al. (2018) American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/ American Stroke Association. Stroke 49: 46-110.5. Tomsick TA, Foster LD, Liebeskind DS, Hill MD, Carrozella J, et al. (2015) IMS III Investigators. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. AJNR Am J Neuroradiol 36: 2074-2081.6. Aviv RI, d’Esterre CD, Murphy BD, Hopyan JJ, Buck B, et al. (2009) Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology 250: 867-877.7. Wardlaw J M, Seymour J, Cairns J, Keir S, Lewis S, et al. (2004) Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life. Stroke 35: 2477-2483. 8. Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, et al. (2009) Ionic Low-Osmolar versus Non-ionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients: The ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after 10 angioplasties in chronic renal failure patients) Study. J Am Coll Cardiol Intv 2: 415-4219. Romano G, Briguori C, Quintavalle C, Zanca C, Rivera NV, et al. (2008) Contrast agents and renal cell apoptosis. Eur Heart J 29: 2569-2276.10. Sendeski M M (2011) Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 38: 292-299.11. Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 100: S11-S15. 12. Liu ZZ, Schmerbach K, Lu Y, Perlewitz A, Nikitina T, et al. (2014) Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubulo-glomerular feedback. Am J Physiol Renal Physiol 306: 864-872.13. Heyman S N, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 3: 288-296.14. Schick CS, Haller C (1999) Comparative cytotoxicity of ionic and non ionic radio contrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 14: 342-347.15. Hardiek K, Katholi RE, Ramkumar V, Deitrick C (2001) Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 280: 61-70.16. Quintavalle C, Brenca M, De Micco F, Fiore D, Romano S, et al. (2011) In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis 2: e155.17. Dong M, Jiao Z, Liu T, Guo F, Li G (2012) Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J. Nephrol. 25:290-301.18. Murphy A, Campos A, Hutson R, Bell D (2016) Iodinated contrast media. Radiopaedia.org. https://radiopaedia.org/articles/iodinated-contrast-media-1?lang=us 19. Richard Solomon (2014) Contrast Media: Are There Differences in Nephrotoxicity among Contrast Media? BioMed Research International 2014: 93494720. Gospos C, Freudenberg N, Staubesand J, Mathias K, Papacharlampos X (1983) The effect of contrast media on the aortic endothelium of rats. Radiology 147: 685-688.21. Mc Cullough P A, Bertrand M E, Brinker J A, Stacul F (2006) A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am. Coll.Cardiol 48: 692-699.22. Mc Cullough PA, David G, Todoran TM, Brilakis ES, Ryan MP, et al. (2018) Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention. J Comp Eff Res 7: 331-341.23. Morales H, Lu A, Kurosawa Y, Clark JF, Tomsick T, et al. (2017) Variable MR and pathologic patterns of hemorrhage after iodinated contrast infusion in MCA occlusion/reperfusion model. J Neurointer Surg 9: 1248-1252. 24. Moser FG, Todoran TM, Ryan M, Baker E, Gunnarsson C, et al. (2022) Hemorrhagic Transformation Rates following Contrast Media Administration in Patients Hospitalized with Ischemic Stroke. AJNR Am J Neuroradiol 43: 381-387.25. Jost G, Lengsfeld P, Lenhard DC, Pietsch H, Hütter J, et al. (2011) Viscosity of iodinated contrast agents during renal excretion. Eur J Radiol 80: 373-377.26. Ueda J, Furukawa T, Higashino K, Takahashi S, Araki Y, et al. (1997) Urine viscosity after injections of iotrolan or iomeprol. Acta Radiologica 38: 1079-1082.27. Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, et al. (2005) Cytotoxic effects of ionic high osmolar, non ionic monomeric, and non-ionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 235: 843-849.28. Bertrand ME, Esplugas E, Piessens J, Rasch W (2000) Influence of a non-ionic iso-osmolar contrast-medium (iodixanol) versus an ionic low osmolar Contrast Medium (Ioxaglate) on Major Adverse Cardiac Events in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty. Circulation 101: 131-136.29. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491–499.30. Barrett BJ, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:379-386.31. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC (1986) Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104: 501-504.32. Cigarroa RG, Lange RA, Williams RH, Hillis LD (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86: 649-652.33. Freeman RV, O’Donnell M, Share D, Meengs WL, Kline Rogers E, et al. (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90: 1068-1073.34. Aayush J, Amandeep K, Sidak PS, Birinder PS, Dinesh J (2024) Dehydration in acute stroke: Risk factors and outcome. International Journal of Life Sciences, Biotechnology and Pharma Research 13. 35. Luo Y, Wang X, Ye Z, Lai Y, Yao Y, et al. (2014) Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. Intern Med 53: 2265-2272.36. Igarashi G, Iino K, Watanabe H, Ito H (2013) Remote ischemic preconditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease. Circ J 77: 3037-3044.37. Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, et al. (2012) Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation 126: 296-303.38. KDIGO (2012) Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl: 2:8 https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf 39. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291: 2328–233440. Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, et al. (2007) Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol 28: 1292-1298.41. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, et al. (2019) American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics- 2019 Update: a report from the American Heart Association. Circulation 139: e56-528. 42. Hom J, Dankbaar JW, Soares BP, Schneider T, Cheng SC, et al. (2011) Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant oedema in acute ischemic stroke. AJNR Am / Neuroradiol 32: 41-48.
Authors: Oluwafemi Ajoyemi ALA, Lawal Saidat Abisola
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4405422768
FWCI:
Cites:
Cited by:
Related to: 10